Cochrane · systematic review · CD006731
Pharmaceutical policies: effects of financial incentives for prescribers
Rashidian, A, Omidvari, AH, Vali, Y, et al. · Cochrane Database of Systematic Reviews · 2015 · Cochrane Library
Effective Practice and Organisation of CareAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
11
current version
GRADE rated
8
No studies
3
Included studies
NR
No studies 3 · 27.3%Ungraded 0 · 0%Very low 7 · 63.6%Low 1 · 9.1%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Summary of findings: drug budget policies
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Drug use (item per patient or prescription) | no estimate extracted | NR | Low |
Drug use (generic percentage) | no estimate extracted | NR | Very low |
Costs per item | no estimate extracted | NR | Very low |
Costs per patient or prescription | no estimate extracted | NR | Very low |
Total costs | no estimate extracted | NR | Very low |
Healthcare utilisation (referral to outpatient specialists) | no estimate extracted | NR | Very low |
Health outcomes | no estimate extracted | NR | No studies |
Summary of findings: pay for performance policies
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Drug use | no estimate extracted | NR | Very low |
Costs | no estimate extracted | NR | No studies |
Healthcare utilisation | no estimate extracted | NR | No studies |
Health outcomes | no estimate extracted | NR | Very low |